{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:59:59Z","timestamp":1793073599147,"version":"4.5.0"},"reference-count":218,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10787-025-01980-y","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T19:18:21Z","timestamp":1761938301000},"page":"7217-7254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Revolutionizing osteoporosis management: the emerging role of immunotherapeutic and next-generation therapies"],"prefix":"10.1007","volume":"33","author":[{"given":"Ali","family":"Afshari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Karami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4670-7127","authenticated-orcid":false,"given":"Mitra","family":"Abbasifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"2","key":"1980_CR1","first-page":"71","volume":"8","author":"M Abbasifard","year":"2023","unstructured":"Abbasifard M, Torabzadeh AM, Kamiab Z (2023) Osteoporosis knowledge, attitude and practice among nurses in Rafsanjan, 2020. Rheumatol Res 8(2):71\u201377","journal-title":"Rheumatol Res"},{"key":"1980_CR2","doi-asserted-by":"crossref","unstructured":"Abbasifard, M., K. Jafarizadeh, M. Taghipoor and Z. Bagheri-Hosseinabadi (2024). \"Association of vitamin D levels with bone density in patients with osteoporosis.\"","DOI":"10.21203\/rs.3.rs-4930139\/v1"},{"issue":"4","key":"1980_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziae016","volume":"8","author":"G Adami","year":"2024","unstructured":"Adami G, Pedrollo E, Rossini M, Fassio A, Braga V, Pasetto E, Pollastri F, Benini C, Viapiana O, Gatti D (2024) Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study. JBMR plus 8(4):ziae016","journal-title":"JBMR plus"},{"key":"1980_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2502","volume":"10","author":"IE Adamopoulos","year":"2008","unstructured":"Adamopoulos IE, Bowman EP (2008) Immune regulation of bone loss by Th17 cells. Arthritis Res Ther 10:1\u20139","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"1980_CR5","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3390\/ijms22062851","volume":"22","author":"DS Amarasekara","year":"2021","unstructured":"Amarasekara DS, Kim S, Rho J (2021) Regulation of osteoblast differentiation by cytokine networks. Int J Mol Sci 22(6):2851","journal-title":"Int J Mol Sci"},{"key":"1980_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.lfs.2016.01.024","volume":"147","author":"J An","year":"2016","unstructured":"An J, Yang H, Zhang Q, Liu C, Zhao J, Zhang L, Chen B (2016) Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation. Life Sci 147:46\u201358","journal-title":"Life Sci"},{"issue":"1","key":"1980_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010152","volume":"10","author":"AD Anastasilakis","year":"2021","unstructured":"Anastasilakis AD, Makras P, Yavropoulou MP, Tabacco G, Naciu AM, Palermo A (2021) Denosumab discontinuation and the rebound phenomenon: a narrative review. J Clin Med 10(1):152","journal-title":"J Clin Med"},{"issue":"9","key":"1980_CR8","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1093\/jbmr\/zjae106","volume":"39","author":"AD Anastasilakis","year":"2024","unstructured":"Anastasilakis AD, Polyzos SA, Makras P, Savvidis M, Mantzoros CS (2024) The comparative effect of teriparatide and denosumab on activins, follistatins, and inhibins in women with postmenopausal osteoporosis. J Bone Miner Res 39(9):1306\u20131314","journal-title":"J Bone Miner Res"},{"issue":"14","key":"1980_CR9","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial. JAMA 291(14):1701\u20131712","journal-title":"JAMA"},{"key":"1980_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116468","volume":"162","author":"D Andreev","year":"2022","unstructured":"Andreev D, Kachler K, Schett G, Bozec A (2022) Rheumatoid arthritis and osteoimmunology: the adverse impact of a deregulated immune system on bone metabolism. Bone 162:116468","journal-title":"Bone"},{"issue":"3","key":"1980_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ecl.2012.04.006","volume":"41","author":"LA Armas","year":"2012","unstructured":"Armas LA, Recker RR (2012) Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol Metab Clin North Am 41(3):475\u2013486","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"1980_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2022.100302","volume":"2","author":"Z Azam","year":"2022","unstructured":"Azam Z, Sapra L, Bhardwaj A, Yadav S, Mishra PK, Shukla P, Sharma V, Srivastava RK (2022) Crocin attenuates osteoclastogenesis and enhances bone health by skewing the immunoporotic \u201cTreg-Th17\u201d cell axis in post-menopausal osteoporotic mice model. Phytomed plus 2(3):100302","journal-title":"Phytomed plus"},{"issue":"3","key":"1980_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/humupd\/dmg017","volume":"9","author":"J Balasch","year":"2003","unstructured":"Balasch J (2003) Sex steroids and bone: current perspectives. Hum Reprod Update 9(3):207\u2013222","journal-title":"Hum Reprod Update"},{"issue":"4","key":"1980_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron R, Ferrari S, Russell RGG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48(4):677\u2013692","journal-title":"Bone"},{"key":"1980_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-14652-7","volume-title":"Osteoporosis in Clinical Practice","author":"R Bartl","year":"2023","unstructured":"Bartl R (2023) Osteoporosis in Clinical Practice. Springer"},{"key":"1980_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120936","volume":"275","author":"L Batoon","year":"2021","unstructured":"Batoon L, Millard SM, Raggatt LJ, Sandrock C, Pickering E, Williams K, Sun LW, Wu AC, Irvine KM, Pivonka P (2021) Treatment with a long-acting chimeric CSF1 molecule enhances fracture healing of healthy and osteoporotic bones. Biomaterials 275:120936","journal-title":"Biomaterials"},{"issue":"8","key":"1980_CR17","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1359\/JBMR.040512","volume":"19","author":"Bauer, D. C., D. M. Black, P. Garnero, M. Hochberg, S. Ott, J. Orloff, D. E. Thompson, S. K. Ewing, P. D. Delmas and F. I. T. S. Group","year":"2004","unstructured":"Bauer, D. C., D. M. Black, P. Garnero, M. Hochberg, S. Ott, J. Orloff, D. E. Thompson, S. K. Ewing, P. D. Delmas and F. I. T. S. Group (2004) Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J Bone Miner Res 19(8):1250\u20131258","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1980_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bone.2010.08.008","volume":"49","author":"T Bellido","year":"2011","unstructured":"Bellido T, Plotkin LI (2011) Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability. Bone 49(1):50\u201355","journal-title":"Bone"},{"issue":"1","key":"1980_CR19","doi-asserted-by":"publisher","first-page":"16155","DOI":"10.1038\/s41598-021-95640-0","volume":"11","author":"H Bhadricha","year":"2021","unstructured":"Bhadricha H, Patel V, Singh AK, Savardekar L, Patil A, Surve S, Desai M (2021) Increased frequency of Th17 cells and IL-17 levels are associated with low bone mineral density in postmenopausal women. Sci Rep 11(1):16155","journal-title":"Sci Rep"},{"key":"1980_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejphar.2018.02.028","volume":"826","author":"S Bhattacharyya","year":"2018","unstructured":"Bhattacharyya S, Pal S, Chattopadhyay N (2018) Targeted inhibition of sclerostin for post-menopausal osteoporosis therapy: a critical assessment of the mechanism of action. Eur J Pharmacol 826:39\u201347","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1980_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jbmr.1494","volume":"27","author":"DM Black","year":"2012","unstructured":"Black DM, Reid IR, Boonen S, Bucci-Rechtweg C, Cauley JA, Cosman F, Cummings SR, Hue TF, Lippuner K, Lakatos P (2012) The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res 27(2):243\u2013254","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1980_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jama.2009.50","volume":"301","author":"D Bliuc","year":"2009","unstructured":"Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301(5):513\u2013521","journal-title":"JAMA"},{"issue":"7","key":"1980_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","volume":"5","author":"HG Bone","year":"2017","unstructured":"Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR, Czerwi\u0144ski E, Fahrleitner-Pammer A, Kendler DL, Lippuner K (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5(7):513\u2013523","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1980_CR24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2165\/00007256-200535090-00004","volume":"35","author":"KT Borer","year":"2005","unstructured":"Borer KT (2005) Physical activity in the prevention and amelioration of osteoporosis in women: interaction of mechanical, hormonal and dietary factors. Sports Med 35:779\u2013830","journal-title":"Sports Med"},{"issue":"5","key":"1980_CR25","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1177\/1060028017748649","volume":"52","author":"EG Boyce","year":"2018","unstructured":"Boyce EG, Mai Y, Pham C (2018) Abaloparatide: review of a next-generation parathyroid hormone agonist. Ann Pharmacother 52(5):462\u2013472","journal-title":"Ann Pharmacother"},{"key":"1980_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11914-017-0356-1","volume":"15","author":"A Bozec","year":"2017","unstructured":"Bozec A, Zaiss MM (2017) T regulatory cells in bone remodelling. Curr Osteoporos Rep 15:121\u2013125","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"1980_CR27","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/jbmr.4409","volume":"36","author":"JP Brown","year":"2021","unstructured":"Brown JP, Engelke K, Keaveny TM, Chines A, Chapurlat R, Foldes AJ, Nogues X, Civitelli R, De Villiers T, Massari F (2021) Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial. J Bone Miner Res 36(11):2139\u20132152","journal-title":"J Bone Miner Res"},{"key":"1980_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115951","volume":"219","author":"X Cai","year":"2024","unstructured":"Cai X, Li Z, Yao Y, Zheng Y, Zhang M, Ye Y (2024) Glycolithocholic acid increases the frequency of circulating Tregs through constitutive androstane receptor to alleviate postmenopausal osteoporosis. Biochem Pharmacol 219:115951","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1980_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10522-024-10146-2","volume":"26","author":"S Chaudhary","year":"2025","unstructured":"Chaudhary S, Kaur P, Singh TA, Bano KS, Vyas A, Mishra AK, Singh P, Mehdi MM (2025) The dynamic crosslinking between gut microbiota and inflammation during aging: reviewing the nutritional and hormetic approaches against dysbiosis and inflammaging. Biogerontology 26(1):1","journal-title":"Biogerontology"},{"issue":"9","key":"1980_CR30","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.3390\/ijms20092213","volume":"20","author":"L-R Chen","year":"2019","unstructured":"Chen L-R, Ko N-Y, Chen K-H (2019) Medical treatment for osteoporosis: from molecular to clinical opinions. Int J Mol Sci 20(9):2213","journal-title":"Int J Mol Sci"},{"key":"1980_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40659-021-00366-y","volume":"54","author":"T Chen","year":"2021","unstructured":"Chen T, Yang T, Zhang W, Shao J (2021a) The therapeutic potential of mesenchymal stem cells in treating osteoporosis. Biol Res 54:1\u201312","journal-title":"Biol Res"},{"key":"1980_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.588095","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhu J, Zhou Y, Peng J, Wang B (2021b) Efficacy and safety of denosumab in osteoporosis or low bone mineral density postmenopausal women. Front Pharmacol 12:588095","journal-title":"Front Pharmacol"},{"issue":"3","key":"1980_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031376","volume":"23","author":"C-H Cheng","year":"2022","unstructured":"Cheng C-H, Chen L-R, Chen K-H (2022) Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Int J Mol Sci 23(3):1376","journal-title":"Int J Mol Sci"},{"key":"1980_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/BF01880410","volume":"1","author":"C Christiansen","year":"1990","unstructured":"Christiansen C, Lindsay R (1990) Estrogens, bone loss and preservation. Osteoporos Int 1:7\u201313","journal-title":"Osteoporos Int"},{"issue":"4","key":"1980_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/biom11040506","volume":"11","author":"\u017b Ciosek","year":"2021","unstructured":"Ciosek \u017b, Kot K, Kosik-Bogacka D, \u0141anocha-Arendarczyk N, Rotter I (2021) The effects of calcium, magnesium, phosphorus, fluoride, and lead on bone tissue. Biomolecules 11(4):506","journal-title":"Biomolecules"},{"key":"1980_CR36","unstructured":"Clasey J. L. (1993) Physical activity, estrogen replacement therapy and bone mineral density in early postmenopausal women, University of Illinois at Urbana-Champaign."},{"issue":"1","key":"1980_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010221","volume":"12","author":"VJ Clemente-Su\u00e1rez","year":"2024","unstructured":"Clemente-Su\u00e1rez VJ, Redondo-Fl\u00f3rez L, Rubio-Zarapuz A, Mart\u00edn-Rodr\u00edguez A, Tornero-Aguilera JF (2024) Microbiota implications in endocrine-related diseases: from development to novel therapeutic approaches. Biomedicines 12(1):221","journal-title":"Biomedicines"},{"issue":"1","key":"1980_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0378-5122(99)00090-0","volume":"34","author":"FJ Cohen","year":"2000","unstructured":"Cohen FJ, Lu Y (2000) Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials. Maturitas 34(1):65\u201373","journal-title":"Maturitas"},{"key":"1980_CR39","first-page":"1827","volume-title":"Romosozumab for the treatment of postmenopausal osteoporosis","author":"F Cosman","year":"2021","unstructured":"Cosman F, Saag KG (2021) Romosozumab for the treatment of postmenopausal osteoporosis. Elsevier, Marcus and Feldman\u2019s Osteoporosis, pp 1827\u20131833"},{"issue":"5","key":"1980_CR40","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1517\/14712598.2014.895808","volume":"14","author":"AG Costa","year":"2014","unstructured":"Costa AG, Bilezikian JP, Lewiecki EM (2014) Update on romosozumab: a humanized monoclonal antibody to sclerostin. Expert Opin Biol Ther 14(5):697\u2013707","journal-title":"Expert Opin Biol Ther"},{"issue":"8","key":"1980_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-234508","volume":"13","author":"N Daga","year":"2020","unstructured":"Daga N, Joseph F (2020) Denosumab-induced severe hypocalcaemia in a patient with vitamin D deficiency. BMJ Case Reports CP 13(8):e234508","journal-title":"BMJ Case Reports CP"},{"issue":"10","key":"1980_CR42","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1093\/jbmr\/zjae128","volume":"39","author":"KM Dahir","year":"2024","unstructured":"Dahir KM, Shannon A, Dunn D, Voegtli W, Dong Q, Hasan J, Pradhan R, Pelto R, Pan W-J (2024) Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia. J Bone Miner Res 39(10):1412\u20131423","journal-title":"J Bone Miner Res"},{"key":"1980_CR43","doi-asserted-by":"publisher","DOI":"10.1201\/9781003375081","volume-title":"Fracture and Fatigue Characterisation of Cortical Bone Tissue","author":"MF de Moura","year":"2024","unstructured":"de Moura MF, Dourado N (2024) Fracture and Fatigue Characterisation of Cortical Bone Tissue. CRC Press"},{"key":"1980_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","volume":"96","author":"J Delgado-Calle","year":"2017","unstructured":"Delgado-Calle J, Sato AY, Bellido T (2017) Role and mechanism of action of sclerostin in bone. Bone 96:29\u201337","journal-title":"Bone"},{"issue":"10","key":"1980_CR45","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/term.1851","volume":"9","author":"R Detsch","year":"2015","unstructured":"Detsch R, Boccaccini AR (2015) The role of osteoclasts in bone tissue engineering. J Tissue Eng Regen Med 9(10):1133\u20131149","journal-title":"J Tissue Eng Regen Med"},{"issue":"9","key":"1980_CR46","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1080\/14740338.2024.2386365","volume":"23","author":"DL Diab","year":"2024","unstructured":"Diab DL, Watts NB (2024) The use of denosumab in osteoporosis\u2013an update on efficacy and drug safety. Expert Opin Drug Saf 23(9):1069\u20131077","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"1980_CR47","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s00774-021-01246-x","volume":"39","author":"Y Ding","year":"2021","unstructured":"Ding Y, Cui Y, Yang X, Wang X, Tian G, Peng J, Wu B, Tang L, Cui C-P, Zhang L (2021) Anti-RANKL monoclonal antibody and bortezomib prevent mechanical unloading-induced bone loss. J Bone Miner Metab 39(6):974\u2013983","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"1980_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1319","volume":"12","author":"S Ding","year":"2024","unstructured":"Ding S, Ren T, Song S, Peng C, Liu C, Wu J, Chang X (2024) Combined application of mesenchymal stem cells and different glucocorticoid dosing alleviates osteoporosis in SLE murine models. Immunity Inflamm Dis 12(6):e1319","journal-title":"Immunity Inflamm Dis"},{"issue":"8","key":"1980_CR49","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00198-022-06386-y","volume":"33","author":"K Ebina","year":"2022","unstructured":"Ebina K, Etani Y, Tsuboi H, Nagayama Y, Kashii M, Miyama A, Kunugiza Y, Hirao M, Okamura G, Noguchi T (2022) Effects of prior osteoporosis treatment on the treatment response of romosozumab followed by denosumab in patients with postmenopausal osteoporosis. Osteoporos Int 33(8):1807\u20131813","journal-title":"Osteoporos Int"},{"issue":"7","key":"1980_CR50","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jama.282.7.637","volume":"282","author":"B Ettinger","year":"1999","unstructured":"Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 282(7):637\u2013645","journal-title":"JAMA"},{"issue":"8","key":"1980_CR51","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1200\/JCO.2005.11.005","volume":"23","author":"CJ Fabian","year":"2005","unstructured":"Fabian CJ, Kimler BF (2005) Selective estrogen-receptor modulators for primary prevention of breast cancer. J Clin Oncol 23(8):1644\u20131655","journal-title":"J Clin Oncol"},{"issue":"11","key":"1980_CR52","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.3390\/jcm9113439","volume":"9","author":"S Fabre","year":"2020","unstructured":"Fabre S, Funck-Brentano T, Cohen-Solal M (2020) Anti-sclerostin antibodies in osteoporosis and other bone diseases. J Clin Med 9(11):3439","journal-title":"J Clin Med"},{"issue":"7","key":"1980_CR53","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1359\/jbmr.090216","volume":"24","author":"A Fahrleitner-Pammer","year":"2009","unstructured":"Fahrleitner-Pammer A, Piswanger-Soelkner JC, Pieber TR, Obermayer-Pietsch BM, Pilz S, Dimai HP, Prenner G, Tscheliessnigg KH, Hauge E, Portugaller RH (2009) Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial. J Bone Miner Res 24(7):1335\u20131344","journal-title":"J Bone Miner Res"},{"key":"1980_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38022","author":"S Fang","year":"2024","unstructured":"Fang S, Ni H, Zhang Q, Dai J, He S, Min J, Zhang W, Li H (2024) Integrated single-cell and bulk RNA sequencing analysis reveal immune-related biomarkers in postmenopausal osteoporosis. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38022","journal-title":"Heliyon"},{"issue":"4","key":"1980_CR55","doi-asserted-by":"publisher","first-page":"0848","DOI":"10.21123\/bsj.2022.19.4.0848","volume":"19","author":"LO Farhan","year":"2022","unstructured":"Farhan LO, Taha EM, Farhan AM (2022) A case control study to determine Macrophage migration inhibitor, and N-telopeptides of type I bone collagen levels in the sera of osteoporosis patients. Baghdad Sci J 19(4):0848\u20130848","journal-title":"Baghdad Sci J"},{"issue":"1","key":"1980_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-024-07512-z","volume":"25","author":"Z Feng","year":"2024","unstructured":"Feng Z, Wu Z, Zhang Y (2024) Integration of bioinformatics and machine learning approaches for the validation of pyrimidine metabolism-related genes and their implications in immunotherapy for osteoporosis. BMC Musculoskelet Disord 25(1):1\u201315","journal-title":"BMC Musculoskelet Disord"},{"key":"1980_CR57","doi-asserted-by":"crossref","unstructured":"Fischer V. and M. Haffner-Luntzer (2022) Interaction between bone and immune cells: Implications for postmenopausal osteoporosis. Seminars in cell & developmental biology, Elsevier.","DOI":"10.1016\/j.semcdb.2021.05.014"},{"key":"1980_CR58","doi-asserted-by":"crossref","unstructured":"Fitzpatrick L. A. (2003) Clinical trials of estrogen and SERMs on bone markers, bone mineral density, and fractures. Osteoporosis: Pathophysiology and Clinical Management Springer: 331\u2013347.","DOI":"10.1007\/978-1-59259-278-4_16"},{"issue":"15","key":"1980_CR59","doi-asserted-by":"publisher","first-page":"8182","DOI":"10.3390\/ijms22158182","volume":"22","author":"Y Gao","year":"2021","unstructured":"Gao Y, Patil S, Jia J (2021) The development of molecular biology of osteoporosis. Int J Mol Sci 22(15):8182","journal-title":"Int J Mol Sci"},{"key":"1980_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1070117","volume":"11","author":"R Gao","year":"2023","unstructured":"Gao R, Zhang W, Jiang Y, Zhai J, Yu J, Liu H, Li M (2023) Eldecalcitol effectively prevents alveolar bone loss by partially improving Th17\/Treg cell balance in diabetes-associated periodontitis. Front Bioeng Biotechnol 11:1070117","journal-title":"Front Bioeng Biotechnol"},{"key":"1980_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1440948","volume":"11","author":"G Gao","year":"2024","unstructured":"Gao G, Cui J, Xie Y, Dong J (2024) Effects of romosozumab combined with routine therapy on pain relief, disease progression and adverse reactions in patients with postmenopausal osteoporosis: a systematic review and meta-analysis. Front Med 11:1440948","journal-title":"Front Med"},{"issue":"24","key":"1980_CR62","doi-asserted-by":"publisher","first-page":"12S","DOI":"10.1097\/00007632-199712151-00003","volume":"22","author":"DL Glaser","year":"1997","unstructured":"Glaser DL, Kaplan FS (1997) Osteoporosis: definition and clinical presentation. Spine 22(24):12S-16S","journal-title":"Spine"},{"key":"1980_CR63","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00198-020-05431-y","volume":"31","author":"P Gomes-Ferreira","year":"2020","unstructured":"Gomes-Ferreira P, de Oliveira D, Frig\u00e9rio P, de Souza Batista F, Grandfield K, Okamoto R (2020) Teriparatide improves microarchitectural characteristics of peri-implant bone in orchiectomized rats. Osteoporos Int 31:1807\u20131815","journal-title":"Osteoporos Int"},{"issue":"2","key":"1980_CR64","first-page":"106","volume":"13","author":"S Gonnelli","year":"2016","unstructured":"Gonnelli S, Caffarelli C (2016) Abaloparatide. Clin Cases Miner Bone Metab 13(2):106","journal-title":"Clin Cases Miner Bone Metab"},{"key":"1980_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2023.105811","volume":"109","author":"J Gu","year":"2023","unstructured":"Gu J, Zheng Y, Yang H, Li Y, Liu S, Wu Y, Ren L, Yu Y, Long Y (2023) Cistanche deserticola polysaccharide regulated the gut microbiota-SCFAs-Th17\/Treg cell axis and ameliorated the inflammation of postmenopausal osteoporosis. J Funct Foods 109:105811","journal-title":"J Funct Foods"},{"key":"1980_CR66","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fimmu.2020.00058","volume":"11","author":"C Guder","year":"2020","unstructured":"Guder C, Gravius S, Burger C, Wirtz DC, Schildberg FA (2020) Osteoimmunology: a current update of the interplay between bone and the immune system. Front Immunol 11:58","journal-title":"Front Immunol"},{"key":"1980_CR67","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221083523","volume":"14","author":"A Gupta","year":"2022","unstructured":"Gupta A, Maslen C, Vindlacheruvu M, Abel RL, Bhattacharya P, Bromiley PA, Clark EM, Compston JE, Crabtree N, Gregory JS (2022) Digital health interventions for osteoporosis and post-fragility fracture care. Ther Adv Musculoskelet Dis 14:1759720X221083523","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"1980_CR68","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1196\/annals.1365.035","volume":"1092","author":"DJ Hadjidakis","year":"2006","unstructured":"Hadjidakis DJ, Androulakis II (2006) Bone remodeling. Ann N Y Acad Sci 1092(1):385\u2013396","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"1980_CR69","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/ijcp.12022","volume":"66","author":"D Hanley","year":"2012","unstructured":"Hanley D, Adachi J, Bell A, Brown V (2012) Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract 66(12):1139\u20131146","journal-title":"Int J Clin Pract"},{"issue":"6","key":"1980_CR70","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00198-023-06708-8","volume":"34","author":"D Hans","year":"2023","unstructured":"Hans D, McDermott M, Huang S, Kim M, Shevroja E, McClung M (2023) Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness\u2013adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension. Osteoporos Int 34(6):1075\u20131084","journal-title":"Osteoporos Int"},{"key":"1980_CR71","doi-asserted-by":"publisher","first-page":"1118886","DOI":"10.3389\/fendo.2023.1118886","volume":"14","author":"S Hao","year":"2023","unstructured":"Hao S, Xinqi M, Weicheng X, Shiwei Y, Lumin C, Xiao W, Dong L, Jun H (2023) Identification of key immune genes of osteoporosis based on bioinformatics and machine learning. Front Endocrinol 14:1118886","journal-title":"Front Endocrinol"},{"key":"1980_CR72","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae484","author":"MC Hartz","year":"2024","unstructured":"Hartz MC, Johannessen FB, Harsl\u00f8f T, Langdahl BL (2024) The effectiveness and safety of romosozumab and teriparatide in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae484","journal-title":"J Clin Endocrinol Metab"},{"key":"1980_CR73","first-page":"419","volume-title":"Testosterone replacement therapy","author":"C Haymana","year":"2022","unstructured":"Haymana C, Sonmez A (2022) Testosterone replacement therapy. Springer, Andrology and Sexual Medicine, pp 419\u2013431"},{"key":"1980_CR74","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jare.2023.01.003","volume":"53","author":"J He","year":"2023","unstructured":"He J, Zheng L, Li X, Huang F, Hu S, Chen L, Jiang M, Lin X, Jiang H, Zeng Y (2023) Obacunone targets macrophage migration inhibitory factor (MIF) to impede osteoclastogenesis and alleviate ovariectomy-induced bone loss. J Adv Res 53:235\u2013248","journal-title":"J Adv Res"},{"key":"1980_CR75","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bone.2016.07.019","volume":"91","author":"K Henriksen","year":"2016","unstructured":"Henriksen K, Byrjalsen I, Andersen JR, Bihlet AR, Russo LA, Alexandersen P, Valter I, Qvist P, Lau E, Riis BJ (2016) A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D. Bone 91:122\u2013129","journal-title":"Bone"},{"issue":"12","key":"1980_CR76","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00198-023-06889-2","volume":"34","author":"N Hong","year":"2023","unstructured":"Hong N, Shin S, Lee S, Rhee Y (2023) Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis. Osteoporos Int 34(12):2059\u20132067","journal-title":"Osteoporos Int"},{"key":"1980_CR77","first-page":"186","volume-title":"Drugs for Treating Gastrointestinal Disorders","author":"JE Houglum","year":"2024","unstructured":"Houglum JE, Harrelson GL, Seefeldt TM (2024) Drugs for Treating Gastrointestinal Disorders. Routledge, Principles of Pharmacology for Athletic Trainers, pp 186\u2013209"},{"issue":"1","key":"1980_CR78","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1038\/s41467-022-33006-4","volume":"13","author":"D Huang","year":"2022","unstructured":"Huang D, Zhao C, Li R, Chen B, Zhang Y, Sun Z, Wei J, Zhou H, Gu Q, Xu J (2022a) Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis. Nat Commun 13(1):5338","journal-title":"Nat Commun"},{"issue":"13","key":"1980_CR79","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1111\/jcmm.17399","volume":"26","author":"F Huang","year":"2022","unstructured":"Huang F, Wong P, Li J, Lv Z, Xu L, Zhu G, He M, Luo Y (2022b) Osteoimmunology: the correlation between osteoclasts and the Th17\/Treg balance in osteoporosis. J Cell Mol Med 26(13):3591\u20133597","journal-title":"J Cell Mol Med"},{"key":"1980_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1182753","volume":"14","author":"S-T Huang","year":"2023","unstructured":"Huang S-T, Chiu T-F, Chiu C-W, Kao Y-N, Wang I-K, Chang C-T, Li C-Y, Sun C-S, Lin C-L, Yu T-M (2023a) Denosumab treatment and infection risks in patients with osteoporosis: propensity score matching analysis of a national-wide population-based cohort study. Front Endocrinol 14:1182753","journal-title":"Front Endocrinol"},{"issue":"6","key":"1980_CR81","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/pds.5594","volume":"32","author":"W Huang","year":"2023","unstructured":"Huang W, Nagao M, Yonemoto N, Guo S, Tanigawa T, Nishizaki Y (2023b) Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials (CDM-J). Pharmacoepidemiol Drug Saf 32(6):671\u2013684","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"1980_CR82","doi-asserted-by":"publisher","first-page":"e2354734","DOI":"10.1001\/jamanetworkopen.2023.54734","volume":"7","author":"H-K Huang","year":"2024","unstructured":"Huang H-K, Chuang AT-M, Liao T-C, Shao S-C, Liu PP-S, Tu Y-K, Lai EC-C (2024) Denosumab and the risk of diabetes in patients treated for osteoporosis. JAMA Netw Open 7(2):e2354734\u2013e2354734","journal-title":"JAMA Netw Open"},{"issue":"5","key":"1980_CR83","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziae021","volume":"8","author":"P Islam","year":"2024","unstructured":"Islam P, Ice JA, Alake SE, Adedigba P, Hatter B, Robinson K, Clarke SL, Ford Versypt AN, Ritchey J, Lucas EA (2024) Fructooligosaccharides act on the gut\u2013bone axis to improve bone independent of Tregs and alter osteocytes in young adult C57BL\/6 female mice. JBMR plus 8(5):ziae021","journal-title":"JBMR plus"},{"issue":"1","key":"1980_CR84","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1186\/s12891-022-05997-0","volume":"23","author":"L Jiang","year":"2022","unstructured":"Jiang L, Dong J, Wei J, Liu L (2022) Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis. BMC Musculoskelet Disord 23(1):1027","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"1980_CR85","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-024-05453-3","volume":"81","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Gao R, Ying Q, Li X, Dai Y, Song A, Liu H, Hasegawa T, Li M (2024) Eldecalcitol ameliorates diabetic osteoporosis and glucolipid metabolic disorder by promoting Treg cell differentiation through SOCE. Cell Mol Life Sci 81(1):423","journal-title":"Cell Mol Life Sci"},{"key":"1980_CR86","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/bs.vh.2020.12.016","volume":"115","author":"AS Karlamangla","year":"2021","unstructured":"Karlamangla AS, Shieh A, Greendale GA, Elsevier (2021) Hormones and bone loss across the menopause transition. Vitam Horm 115:401\u2013417","journal-title":"Vitam Horm"},{"issue":"16","key":"1980_CR87","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.2174\/1389450121666200731173522","volume":"21","author":"M Kaur","year":"2020","unstructured":"Kaur M, Nagpal M, Singh M (2020) Osteoblast-n-osteoclast: making headway to osteoporosis treatment. Curr Drug Targets 21(16):1640\u20131651","journal-title":"Curr Drug Targets"},{"key":"1980_CR88","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bone.2016.03.016","volume":"87","author":"AB Khalid","year":"2016","unstructured":"Khalid AB, Krum SA (2016) Estrogen receptors alpha and beta in bone. Bone 87:130\u2013135","journal-title":"Bone"},{"issue":"11","key":"1980_CR89","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","volume":"23","author":"S Khosla","year":"2012","unstructured":"Khosla S, Oursler MJ, Monroe DG (2012) Estrogen and the skeleton. Trends Endocrinol Metab 23(11):576\u2013581","journal-title":"Trends Endocrinol Metab"},{"key":"1980_CR90","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2024.2316846","author":"A Kim","year":"2024","unstructured":"Kim A, Hong JH, Shin W, Yoo H, Jung J-G, Reginster J-Y, Kim S, Bae Y, Suh J, Kim S (2024) A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT-P41 and reference denosumab in healthy males. Expert Opin Biol Ther. https:\/\/doi.org\/10.1080\/14712598.2024.2316846","journal-title":"Expert Opin Biol Ther"},{"issue":"14","key":"1980_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145169","volume":"21","author":"H Kitaura","year":"2020","unstructured":"Kitaura H, Marahleh A, Ohori F, Noguchi T, Shen W-R, Qi J, Nara Y, Pramusita A, Kinjo R, Mizoguchi I (2020) Osteocyte-related cytokines regulate osteoclast formation and bone resorption. Int J Mol Sci 21(14):5169","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1980_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91248-6","volume":"11","author":"T Kobayakawa","year":"2021","unstructured":"Kobayakawa T, Miyazaki A, Saito M, Suzuki T, Takahashi J, Nakamura Y (2021) Denosumab versus romosozumab for postmenopausal osteoporosis treatment. Sci Rep 11(1):11801","journal-title":"Sci Rep"},{"key":"1980_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116480","volume":"162","author":"T Kobayakawa","year":"2022","unstructured":"Kobayakawa T, Miyazaki A, Takahashi J, Nakamura Y (2022) Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment with romosozumab as sequential therapy: the prospective VICTOR study. Bone 162:116480","journal-title":"Bone"},{"issue":"2","key":"1980_CR94","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1359\/jbmr.081112","volume":"24","author":"PJ Kostenuik","year":"2009","unstructured":"Kostenuik PJ, Nguyen HQ, McCabe J, Warmington KS, Kurahara C, Sun N, Chen C, Li L, Cattley RC, Van G (2009) Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL. J Bone Miner Res 24(2):182\u2013195","journal-title":"J Bone Miner Res"},{"key":"1980_CR95","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/BF03343616","volume":"22","author":"GG Kuiper","year":"1999","unstructured":"Kuiper GG, van den Bemd G-J, Van Leeuwen J (1999) Estrogen receptor and the SERM concept. J Endocrinol Invest 22:594\u2013603","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1980_CR96","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3906\/sag-2005-315","volume":"51","author":"FY Kutsal","year":"2021","unstructured":"Kutsal FY, Ergani GOE (2021) Vertebral compression fractures: still an unpredictable aspect of osteoporosis. Turk J Med Sci 51(2):393\u2013399","journal-title":"Turk J Med Sci"},{"issue":"5","key":"1980_CR97","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00198-021-06291-w","volume":"33","author":"E-C Lai","year":"2022","unstructured":"Lai E-C, Lin T-C, Lange J, Chen L, Wong I, Sing C-W, Cheung C-L, Shao S-C, Yang Y-HK (2022) Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study. Osteoporos Int 33(5):1155\u20131164","journal-title":"Osteoporos Int"},{"key":"1980_CR98","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae611","author":"B Langdahl","year":"2024","unstructured":"Langdahl B, Chung Y-S, Plebanski R, Czerwinski E, Dokoupilova E, Supronik J, Rosa J, Mydlak A, Rowi\u0144ska-Osuch A, Baek K-H (2024) Proposed denosumab biosimilar SB16 vs reference denosumab in postmenopausal osteoporosis: phase 3 results up to month 12. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae611","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1980_CR99","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","volume":"33","author":"MS LeBoff","year":"2022","unstructured":"LeBoff MS, Greenspan S, Insogna K, Lewiecki E, Saag K, Singer A, Siris E (2022) The clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 33(10):2049\u20132102","journal-title":"Osteoporos Int"},{"key":"1980_CR100","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.freeradbiomed.2021.03.008","volume":"168","author":"C-W Lee","year":"2021","unstructured":"Lee C-W, Lin H-C, Wang BY-H, Wang AY-F, Shin RL-Y, Cheung SYL, Lee OK-S (2021) Ginkgolide B monotherapy reverses osteoporosis by regulating oxidative stress-mediated bone homeostasis. Free Radic Biol Med 168:234\u2013246","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"1980_CR101","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1080\/13543784.2023.2273510","volume":"32","author":"HA Lee","year":"2023","unstructured":"Lee HA, Kim S, Seo H, Kim S (2023) A phase I, randomized, double-blind, single-dose pharmacokinetic study to evaluate the biosimilarity of SB16 (proposed denosumab biosimilar) with reference denosumab in healthy male subjects. Expert Opin Investig Drugs 32(10):959\u2013966","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"1980_CR102","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jbmr.3600","volume":"34","author":"JY Li","year":"2019","unstructured":"Li JY, Yu M, Tyagi AM, Vaccaro C, Hsu E, Adams J, Bellido T, Weitzmann MN, Pacifici R (2019) IL-17 receptor signaling in osteoblasts\/osteocytes mediates PTH-induced bone loss and enhances osteocytic RANKL production. J Bone Miner Res 34(2):349\u2013360","journal-title":"J Bone Miner Res"},{"key":"1980_CR103","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cytogfr.2020.02.003","volume":"52","author":"J Li","year":"2020","unstructured":"Li J, Chen X, Lu L, Yu X (2020) The relationship between bone marrow adipose tissue and bone metabolism in postmenopausal osteoporosis. Cytokine Growth Factor Rev 52:88\u201398","journal-title":"Cytokine Growth Factor Rev"},{"key":"1980_CR104","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbad006","volume":"10","author":"J Li","year":"2023","unstructured":"Li J, Song J, Meng D, Yi Y, Zhang T, Shu Y, Wu X (2023) Electrospun naringin-loaded microsphere\/sucrose acetate isobutyrate system promotes macrophage polarization toward M2 and facilitates osteoporotic bone defect repair. Regen Biomater 10:rbad006","journal-title":"Regen Biomater"},{"key":"1980_CR105","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S494759","author":"S Li","year":"2024","unstructured":"Li S, Zou J, Ran J, Wang L, Nie G, Liu Y, Tian C, Yang X, Liu Y, Wan J (2024a) Advances in the study of Denosumab treatment for osteoporosis and sarcopenia in the Chinese middle-aged and elderly population. Int J Gen Med. https:\/\/doi.org\/10.2147\/IJGM.S494759","journal-title":"Int J Gen Med"},{"key":"1980_CR106","doi-asserted-by":"crossref","unstructured":"Li W., Z. Xu B. Zou D. Yang Y. Lu X. Zhang C. Zhang Y. Li and C. Zhu (2024) Macrophage regulation in vascularization upon regeneration and repair of tissue injury and engineered organ transplantation. Fundamental Research.","DOI":"10.1016\/j.fmre.2023.12.015"},{"issue":"10","key":"1980_CR107","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4103\/apjtb.apjtb_278_24","volume":"14","author":"J Lian","year":"2024","unstructured":"Lian J, Qu J-L, Zhao G-W, Ji X-B (2024) Antiosteoporosis and bone protective effect of alpinumisoflavone in steroid-induced osteoporosis rats via alteration of apoptosis, inflammatory and RANK\/RANKL\/OPG signaling pathway. Asian Pac J Trop Biomed 14(10):436\u2013447","journal-title":"Asian Pac J Trop Biomed"},{"key":"1980_CR108","first-page":"174550572211255","volume":"18","author":"SY Lim","year":"2022","unstructured":"Lim SY (2022) Romosozumab for the treatment of osteoporosis in women: efficacy, safety, and cardiovascular risk. Womens Health 18:17455057221125576","journal-title":"Womens Health"},{"issue":"4","key":"1980_CR109","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3390\/biom10040526","volume":"10","author":"RP Limgala","year":"2020","unstructured":"Limgala RP, Goker-Alpan O (2020) Effect of substrate reduction therapy in comparison to enzyme replacement therapy on immune aspects and bone involvement in Gaucher disease. Biomolecules 10(4):526","journal-title":"Biomolecules"},{"issue":"1","key":"1980_CR110","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1600-0722.2006.00283.x","volume":"114","author":"D Liu","year":"2006","unstructured":"Liu D, Yao S, Wise GE (2006) Effect of interleukin-10 on gene expression of osteoclastogenic regulatory molecules in the rat dental follicle. Eur J Oral Sci 114(1):42\u201349","journal-title":"Eur J Oral Sci"},{"key":"1980_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.955441","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang D, Cao Y, Zhang H, Li J, Xu J, Yu L, Ye S, Yang L (2022) Screening of crosstalk and pyroptosis-related genes linking periodontitis and osteoporosis based on bioinformatics and machine learning. Front Immunol 13:955441","journal-title":"Front Immunol"},{"issue":"9","key":"1980_CR112","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00198-023-06803-w","volume":"34","author":"K Lu","year":"2023","unstructured":"Lu K, Wu Y-M, Shi Q, Gong Y-Q, Zhang T, Li C (2023) The impact of acute-phase reaction on mortality and re-fracture after zoledronic acid in hospitalized elderly osteoporotic fracture patients. Osteoporos Int 34(9):1613\u20131623","journal-title":"Osteoporos Int"},{"issue":"5","key":"1980_CR113","first-page":"6605","volume":"17","author":"G Luo","year":"2018","unstructured":"Luo G, Li F, Li X, Wang ZG, Zhang B (2018) TNF-\u03b1 and RANKL promote osteoclastogenesis by upregulating RANK via the NF-\u03baB pathway. Mol Med Rep 17(5):6605\u20136611","journal-title":"Mol Med Rep"},{"key":"1980_CR114","doi-asserted-by":"crossref","unstructured":"Lyu H., S. S. Zhao L. Zhang J. Wei X. Li H. Li Y. Liu P. Yin V. Norvang and K. Yoshida (2023) Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study. bmj 381.","DOI":"10.1136\/bmj-2022-073435"},{"key":"1980_CR115","doi-asserted-by":"crossref","unstructured":"Marcus R. and S. Majumder (2001) The nature of osteoporosis. Osteoporosis: 3\u201317.","DOI":"10.1016\/B978-012470862-4\/50036-2"},{"key":"1980_CR116","unstructured":"Marcus R., D. W. Dempster J. A. Cauley and D. Feldman (2013) Osteoporosis, Academic press."},{"key":"1980_CR117","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fendo.2020.00386","volume":"11","author":"M Maruyama","year":"2020","unstructured":"Maruyama M, Rhee C, Utsunomiya T, Zhang N, Ueno M, Yao Z, Goodman SB (2020) Modulation of the inflammatory response and bone healing. Front Endocrinol 11:386","journal-title":"Front Endocrinol"},{"key":"1980_CR118","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF01623654","volume":"5","author":"P Maxim","year":"1995","unstructured":"Maxim P, Ettinger B, Spitalny G (1995) Fracture protection provided by long-term estrogen treatment. Osteoporos Int 5:23\u201329","journal-title":"Osteoporos Int"},{"issue":"2","key":"1980_CR119","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/1574884711308020006","volume":"8","author":"Y Maximov","year":"2013","unstructured":"Maximov Y, Lee TM, Jordan VC (2013) The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice. Curr Clin Pharmacol 8(2):135\u2013155","journal-title":"Curr Clin Pharmacol"},{"key":"1980_CR120","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjae194","author":"MR McClung","year":"2024","unstructured":"McClung MR, Betah D, Leder BZ, Kendler DL, Oates M, Timoshanko J, Wang Z (2024) Romosozumab improves microarchitecture as assessed by tissue thickness\u2013adjusted trabecular bone score in postmenopausal women with osteoporosis. J Bone Miner Res. https:\/\/doi.org\/10.1093\/jbmr\/zjae194","journal-title":"J Bone Miner Res"},{"key":"1980_CR121","doi-asserted-by":"crossref","unstructured":"Mehvish H. B., S. Zhang Y. Liang D. Sun, X. Qiu K. Qu X. Qin J. Li F. Yan and C. Lang (2025) Enhanced Osteoporosis Treatment via Nano Drug Coating Encapsulating Lactobacillus rhamnosus GG. ACS Applied Materials & Interfaces.","DOI":"10.1021\/acsami.4c17985"},{"key":"1980_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.compositesb.2024.111358","volume":"276","author":"F Meng","year":"2024","unstructured":"Meng F, Wang G, Zhou F, Li G, Wang M, Zhou Z, Han Y, Chen X, Hu Y, Zhang Y (2024) Exosomes from young plasma alleviate osteoporosis through miR-217-5p-regulated osteogenesis of bone marrow mesenchymal stem cell. Compos Part B Eng 276:111358","journal-title":"Compos Part B Eng"},{"issue":"5","key":"1980_CR123","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1210\/clinem\/dgac667","volume":"108","author":"Z Messner","year":"2023","unstructured":"Messner Z, Carro V\u00e1zquez D, Haschka J, Grillari J, Resch H, Muschitz C, Pietschmann P, Zwerina J, Hackl M, Kocijan R (2023) Circulating miRNAs respond to denosumab treatment after 2 years in postmenopausal women with osteoporosis\u2014the MiDeTe study. J Clin Endocrinol Metab 108(5):1154\u20131165","journal-title":"J Clin Endocrinol Metab"},{"key":"1980_CR124","doi-asserted-by":"publisher","first-page":"57219","DOI":"10.12775\/JEHS.2025.77.57219","volume":"77","author":"A Mikosi\u0144ska","year":"2025","unstructured":"Mikosi\u0144ska A, Litwin M, Parys J, Ka\u0142uziak P, Witek A, Ka\u017amierczak M, Jesionek S, Jajczak M, Mossakowski M (2025) Therapeutic potential of bisphosphonates-review of medical indications, mechanism of action, interactions and adverse effects. J Educ Health Sport 77:57219\u201357219","journal-title":"J Educ Health Sport"},{"issue":"3","key":"1980_CR125","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.afos.2021.08.001","volume":"7","author":"T Mochizuki","year":"2021","unstructured":"Mochizuki T, Yano K, Ikari K, Okazaki K (2021) Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: an open-label, randomized, pilot study. Osteoporosis Sarcopenia 7(3):110\u2013114","journal-title":"Osteoporosis Sarcopenia"},{"issue":"3","key":"1980_CR126","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/mr\/roac059","volume":"33","author":"T Mochizuki","year":"2023","unstructured":"Mochizuki T, Yano K, Ikari K, Hiroshima R, Okazaki K (2023) Comparison of romosozumab versus denosumab treatment on bone mineral density after 1 year in rheumatoid arthritis patients with severe osteoporosis: a randomized clinical pilot study. Mod Rheumatol 33(3):490\u2013495","journal-title":"Mod Rheumatol"},{"key":"1980_CR127","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.bone.2016.11.004","volume":"97","author":"CA Moreira","year":"2017","unstructured":"Moreira CA, Fitzpatrick LA, Wang Y, Recker RR (2017) Effects of abaloparatide-SC (BA058) on bone histology and histomorphometry: the ACTIVE phase 3 trial. Bone 97:314\u2013319","journal-title":"Bone"},{"issue":"1","key":"1980_CR128","volume":"2013","author":"G Mori","year":"2013","unstructured":"Mori G, D\u2032 Amelio P, Faccio R, Brunetti G (2013) The interplay between the bone and the immune system. J Immunol Res 2013(1):720504","journal-title":"J Immunol Res"},{"issue":"6","key":"1980_CR129","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00223-023-01078-z","volume":"112","author":"MR Moshi","year":"2023","unstructured":"Moshi MR, Nicolopoulos K, Stringer D, Ma N, Jenal M, Vreugdenburg T (2023) The clinical effectiveness of denosumab (Prolia\u00ae) for the treatment of osteoporosis in postmenopausal women, compared to bisphosphonates, selective estrogen receptor modulators (SERM), and placebo: a systematic review and network meta-analysis. Calcif Tissue Int 112(6):631\u2013646","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"1980_CR130","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1634\/theoncologist.5-5-388","volume":"5","author":"DB Muchmore","year":"2000","unstructured":"Muchmore DB (2000) Raloxifene: a selective estrogen receptor modulator (SERM) with multiple target system effects. Oncologist 5(5):388\u2013392","journal-title":"Oncologist"},{"issue":"27","key":"1980_CR131","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1098\/rsif.2007.1341","volume":"5","author":"BM Mulvihill","year":"2008","unstructured":"Mulvihill BM, McNamara LM, Prendergast PJ (2008) Loss of trabeculae by mechano-biological means may explain rapid bone loss in osteoporosis. J R Soc Interface 5(27):1243\u20131253","journal-title":"J R Soc Interface"},{"issue":"4","key":"1980_CR132","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/mr\/roab043","volume":"32","author":"K Murata","year":"2022","unstructured":"Murata K, Uozumi R, Hashimoto M, Ebina K, Akashi K, Onishi A, Nagai K, Yoshikawa A, Katayama M, Son Y (2022) The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: the ANSWER cohort study. Mod Rheumatol 32(4):834\u2013838","journal-title":"Mod Rheumatol"},{"issue":"5","key":"1980_CR133","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","volume":"38","author":"G Nancollas","year":"2006","unstructured":"Nancollas G, Tang R, Phipps R, Henneman Z, Gulde S, Wu W, Mangood A, Russell R, Ebetino F (2006) Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone 38(5):617\u2013627","journal-title":"Bone"},{"issue":"1","key":"1980_CR134","first-page":"244","volume":"6","author":"Y Niu","year":"2021","unstructured":"Niu Y, Wang Z, Shi Y, Dong L, Wang C (2021) Modulating macrophage activities to promote endogenous bone regeneration: biological mechanisms and engineering approaches. Bioact Mater 6(1):244\u2013261","journal-title":"Bioact Mater"},{"issue":"5","key":"1980_CR135","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/pst.2161","volume":"20","author":"BM Nugent","year":"2021","unstructured":"Nugent BM, Madabushi R, Buch B, Peiris V, Crentsil V, Miller VM, Bull J, Jenkins MR (2021) Heterogeneity in treatment effects across diverse populations. Pharm Stat 20(5):929\u2013938","journal-title":"Pharm Stat"},{"issue":"3","key":"1980_CR136","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/cei.13271","volume":"196","author":"K Oi","year":"2019","unstructured":"Oi K, Tokunaga T, Kuranobu T, Yukawa K, Kohno H, Yoshida Y, Mokuda S, Hirata S, Sugiyama E (2019) Tumour necrosis factor \u03b1 augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression. Clin Exp Immunol 196(3):392\u2013402","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1980_CR137","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jcb.21983","volume":"106","author":"IR Orriss","year":"2009","unstructured":"Orriss IR, Key ML, Colston KW, Arnett TR (2009) Inhibition of osteoblast function in vitro by aminobisphosphonates. J Cell Biochem 106(1):109\u2013118","journal-title":"J Cell Biochem"},{"key":"1980_CR138","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1590\/S0482-50042012000400009","volume":"52","author":"RMR Pereira","year":"2012","unstructured":"Pereira RMR, d. Carvalho JF, Paula AP, Zerbini C, Domiciano DS, Gon\u00e7alves H, Danowski JS, Marques Neto JF, Mendon\u00e7a L, Bezerra MC (2012) Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis. Rev Bras Reumatol 52:580\u2013593","journal-title":"Rev Bras Reumatol"},{"key":"1980_CR139","doi-asserted-by":"crossref","unstructured":"Pouresmaeili F., B. Kamalidehghan M. Kamarehei and Y. M. Goh (2018). A comprehensive overview on osteoporosis and its risk factors. Therapeutics and clinical risk management: 2029\u20132049.","DOI":"10.2147\/TCRM.S138000"},{"issue":"9","key":"1980_CR140","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1359\/JBMR.050501","volume":"20","author":"R Prince","year":"2005","unstructured":"Prince R, Sipos A, Hossain A, Syversen U, Ish-Shalom S, Marcinowska E, Halse J, Lindsay R, Dalsky GP, Mitlak BH (2005) Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment. J Bone Miner Res 20(9):1507\u20131513","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1980_CR141","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrd3669","volume":"11","author":"K Redlich","year":"2012","unstructured":"Redlich K, Smolen JS (2012) Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov 11(3):234\u2013250","journal-title":"Nat Rev Drug Discov"},{"key":"1980_CR142","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/01.blo.0000200234.99436.24","volume":"443","author":"J-Y Reginster","year":"2006","unstructured":"Reginster J-Y, Devogelaer J-P (2006) Raloxifene reduces fractures in postmenopausal women with osteoporosis. Clin Orthop Relat Res 443:48\u201354","journal-title":"Clin Orthop Relat Res"},{"key":"1980_CR143","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s001980050010","volume":"11","author":"J-Y Reginster","year":"2000","unstructured":"Reginster J-Y, Minne H, Sorensen O, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11:83\u201391","journal-title":"Osteoporos Int"},{"key":"1980_CR144","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-024-07161-x","author":"J-Y Reginster","year":"2024","unstructured":"Reginster J-Y, Czerwinski E, Wilk K, Borowy P, Strzelecka A, Budlewski T, Janowska-Maus M, Szymanowski K, Kwiatek J, Postol S (2024) Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, phase 3 trial in postmenopausal women with osteoporosis. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-024-07161-x","journal-title":"Osteoporos Int"},{"issue":"10","key":"1980_CR145","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.3390\/ijms23105804","volume":"23","author":"V Rella","year":"2022","unstructured":"Rella V, Rotondo C, Altomare A, Cantatore FP, Corrado A (2022) Bone involvement in systemic lupus erythematosus. Int J Mol Sci 23(10):5804","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1980_CR146","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3803\/EnM.2022.1427","volume":"37","author":"Y Rhee","year":"2022","unstructured":"Rhee Y, Chang D-G, Ha J, Kim S, Lee Y, Jo E, Koh J-M (2022) Real-world safety and effectiveness of denosumab in patients with osteoporosis: a prospective, observational study in South Korea. Endocrinol Metab 37(3):497\u2013505","journal-title":"Endocrinol Metab"},{"issue":"15","key":"1980_CR147","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1056\/NEJMoa0810925","volume":"361","author":"PL Riches","year":"2009","unstructured":"Riches PL, McRorie E, Fraser WD, Determann C, Hof R, Ralston SH (2009) Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin. New England J Med 361(15):1459\u20131465","journal-title":"New England J Med"},{"key":"1980_CR148","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00198-003-1425-0","volume":"14","author":"J Ringe","year":"2003","unstructured":"Ringe J, Dorst A, Faber H, Ibach K, Sorenson F (2003) Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study. Osteoporos Int 14:801\u2013807","journal-title":"Osteoporos Int"},{"issue":"2","key":"1980_CR149","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1677\/jme.0.0260079","volume":"26","author":"R Rizzoli","year":"2001","unstructured":"Rizzoli R, Bonjour J, Ferrari S (2001) Osteoporosis, genetics and hormones. J Mol Endocrinol 26(2):79\u201394","journal-title":"J Mol Endocrinol"},{"issue":"43","key":"1980_CR150","doi-asserted-by":"publisher","first-page":"35815","DOI":"10.1074\/jbc.M112.380493","volume":"287","author":"CE Runyan","year":"2012","unstructured":"Runyan CE, Liu Z, Schnaper HW (2012) Phosphatidylinositol 3-kinase and Rab5 GTPase inversely regulate the Smad anchor for receptor activation (SARA) protein independently of transforming growth factor-\u03b21. J Biol Chem 287(43):35815\u201335824","journal-title":"J Biol Chem"},{"issue":"1","key":"1980_CR151","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1297-319X(03)00131-3","volume":"71","author":"N Saidenberg-Kermanac\u2019h","year":"2004","unstructured":"Saidenberg-Kermanac\u2019h N, Cohen-Solal M, Bessis N, De Vernejoul M-C, Boissier M-C (2004) Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine 71(1):9\u201313","journal-title":"Joint Bone Spine"},{"issue":"1","key":"1980_CR152","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00223-022-01031-6","volume":"112","author":"T Saito","year":"2023","unstructured":"Saito T, Mizobuchi M, Kato T, Suzuki T, Fujiwara Y, Kanamori N, Makuuchi M, Honda H (2023) One-year romosozumab treatment followed by one-year denosumab treatment for osteoporosis in patients on hemodialysis: an observational study. Calcif Tissue Int 112(1):34\u201344","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"1980_CR153","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40011-021-01238-x","volume":"91","author":"L Sapra","year":"2021","unstructured":"Sapra L, Azam Z, Rani L, Saini C, Bhardwaj A, Shokeen N, Ahmad A, Mishra GC, Srivastava RK (2021a) \u201cImmunoporosis\u201d: immunology of osteoporosis. Proceed National Acad Sci, India Section B: Biol Sci 91(3):511\u2013519","journal-title":"Proceed National Acad Sci, India Section B: Biol Sci"},{"issue":"1","key":"1980_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80536-2","volume":"11","author":"L Sapra","year":"2021","unstructured":"Sapra L, Dar HY, Bhardwaj A, Pandey A, Kumari S, Azam Z, Upmanyu V, Anwar A, Shukla P, Mishra PK (2021b) Lactobacillus rhamnosus attenuates bone loss and maintains bone health by skewing Treg-Th17 cell balance in Ovx mice. Sci Rep 11(1):1807","journal-title":"Sci Rep"},{"key":"1980_CR155","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s00774-021-01253-y","volume":"39","author":"M Sato","year":"2021","unstructured":"Sato M, Inaba M, Yamada S, Emoto M, Ohno Y, Tsujimoto Y (2021) Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study. J Bone Miner Metab 39:1082\u20131090","journal-title":"J Bone Miner Metab"},{"key":"1980_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687037","volume":"12","author":"Y Saxena","year":"2021","unstructured":"Saxena Y, Routh S, Mukhopadhaya A (2021) Immunoporosis: role of innate immune cells in osteoporosis. Front Immunol 12:687037","journal-title":"Front Immunol"},{"key":"1980_CR157","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00198-002-1340-9","volume":"14","author":"E Seeman","year":"2003","unstructured":"Seeman E (2003) Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int 14:2\u20138","journal-title":"Osteoporos Int"},{"issue":"1","key":"1980_CR158","first-page":"26","volume":"9","author":"M Shafiepour","year":"2024","unstructured":"Shafiepour M, Kahnooji T, Kamiab Z, Kahnoji M, Abbasifard M (2024) Bone mass density in patients with rheumatoid arthritis influence of disease activity. Rheumatol Res 9(1):26\u201337","journal-title":"Rheumatol Res"},{"issue":"4","key":"1980_CR159","doi-asserted-by":"publisher","first-page":"e1528","DOI":"10.1210\/clinem\/dgab850","volume":"107","author":"E Shane","year":"2022","unstructured":"Shane E, Shiau S, Recker RR, Lappe JM, Agarwal S, Kamanda-Kosseh M, Bucovsky M, Stubby J, Cohen A (2022) Denosumab after teriparatide in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 107(4):e1528\u2013e1540","journal-title":"J Clin Endocrinol Metab"},{"key":"1980_CR160","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00198-006-0274-z","volume":"18","author":"S Silverman","year":"2007","unstructured":"Silverman S, Watts N, Delmas P, Lange J, Lindsay R (2007) Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. Osteoporos Int 18:25\u201334","journal-title":"Osteoporos Int"},{"issue":"1","key":"1980_CR161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-021-06095-y","volume":"33","author":"S Singh","year":"2022","unstructured":"Singh S, Dutta S, Khasbage S, Kumar T, Sachin J, Sharma J, Varthya S (2022) A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis. Osteoporos Int 33(1):1\u201312","journal-title":"Osteoporos Int"},{"issue":"1","key":"1980_CR162","first-page":"1","volume":"53","author":"AV Skalny","year":"2024","unstructured":"Skalny AV, Aschner M, Tsatsakis A, Rocha JB, Santamaria A, Spandidos DA, Martins AC, Lu R, Korobeinikova TV, Chen W (2024) Role of vitamins beyond vitamin D 3 in bone health and osteoporosis. Int J Mol Med 53(1):1\u201321","journal-title":"Int J Mol Med"},{"key":"1980_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122463","volume":"340","author":"ATP Souza","year":"2024","unstructured":"Souza ATP, Freitas GP, Lopes HB, Weffort D, Adolpho LF, Gomes MPO, Oliveira FS, Almeida ALG, Beloti MM, Rosa AL (2024) Mesenchymal stem cell-based therapy for osteoporotic bones: effects of the interaction between cells from healthy and osteoporotic rats on osteoblast differentiation and bone repair. Life Sci 340:122463","journal-title":"Life Sci"},{"key":"1980_CR164","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S351918","author":"RK Srivastava","year":"2022","unstructured":"Srivastava RK, Sapra L (2022) The rising era of \u201cImmunoporosis\u201d: role of immune system in the pathophysiology of osteoporosis. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S351918","journal-title":"J Inflamm Res"},{"key":"1980_CR165","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3389\/fimmu.2018.00657","volume":"9","author":"RK Srivastava","year":"2018","unstructured":"Srivastava RK, Dar HY, Mishra PK (2018) Immunoporosis: immunology of osteoporosis\u2014role of T cells. Front Immunol 9:657","journal-title":"Front Immunol"},{"issue":"1","key":"1980_CR166","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","volume":"15","author":"KT Steeve","year":"2004","unstructured":"Steeve KT, Marc P, Sandrine T, Dominique H, Yannick F (2004) IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15(1):49\u201360","journal-title":"Cytokine Growth Factor Rev"},{"key":"1980_CR167","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae173","author":"J Stokar","year":"2024","unstructured":"Stokar J, Szalat A (2024) Cardiovascular safety of romosozumab vs PTH analogues for osteoporosis treatment: a propensity-score-matched cohort study. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae173","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1980_CR168","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s00198-021-06008-z","volume":"32","author":"U Stumpf","year":"2021","unstructured":"Stumpf U, Kraus M, Hadji P (2021) Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis. Osteoporos Int 32(11):2383\u20132387","journal-title":"Osteoporos Int"},{"key":"1980_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112975","volume":"150","author":"P Sun","year":"2022","unstructured":"Sun P, Zhang C, Huang Y, Yang J, Zhou F, Zeng J, Lin Y (2022) Jiangu granule ameliorated OVX rats bone loss by modulating gut microbiota-SCFAs-Treg\/Th17 axis. Biomed Pharmacother 150:112975","journal-title":"Biomed Pharmacother"},{"key":"1980_CR170","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae721","author":"X Sun","year":"2024","unstructured":"Sun X, Bolster MB, Leder BZ, Fan W (2024) Dose-specific effects of denosumab on serum calcium levels in patients with osteoporosis and various renal functions. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae721","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1980_CR171","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1159\/000106484","volume":"27","author":"S Tanaka","year":"2007","unstructured":"Tanaka S (2007) Signaling axis in osteoclast biology and therapeutic targeting in the RANKL\/RANK\/OPG system. Am J Nephrol 27(5):466\u2013478","journal-title":"Am J Nephrol"},{"issue":"3","key":"1980_CR172","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2174\/1568010054022015","volume":"4","author":"Y Tanaka","year":"2005","unstructured":"Tanaka Y, Nakayamada S, Okada Y (2005) Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets-Inflamm Allergy 4(3):325\u2013328","journal-title":"Curr Drug Targets-Inflamm Allergy"},{"key":"1980_CR173","first-page":"190","volume":"48","author":"H Tang","year":"2024","unstructured":"Tang H, Du Y, Tan Z, Li D, Xie J (2024) METTL14-mediated HOXA5 m6A modification alleviates osteoporosis via promoting WNK1 transcription to suppress NLRP3-dependent macrophage pyroptosis. J Orthop Transl 48:190\u2013203","journal-title":"J Orthop Transl"},{"key":"1980_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.875611","volume":"13","author":"H Tao","year":"2022","unstructured":"Tao H, Tao Y, Yang C, Li W, Zhang W, Li X, Gu Y, Hong Y, Yang H, Liu Y (2022) Gut metabolite urolithin A inhibits osteoclastogenesis and senile osteoporosis by enhancing the autophagy capacity of bone marrow macrophages. Front Pharmacol 13:875611","journal-title":"Front Pharmacol"},{"issue":"3","key":"1980_CR175","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1359\/JBMR.051023","volume":"21","author":"JAH Tashjian","year":"2006","unstructured":"Tashjian JAH, Gagel RF (2006) Teriparatide [human PTH (1\u201334)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis. J Bone Miner Res 21(3):354\u2013365","journal-title":"J Bone Miner Res"},{"key":"1980_CR176","doi-asserted-by":"publisher","DOI":"10.2147\/CE.S172820","author":"AD Taylor","year":"2019","unstructured":"Taylor AD, Saag KG (2019) Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy. Core Evid. https:\/\/doi.org\/10.2147\/CE.S172820","journal-title":"Core Evid"},{"issue":"7","key":"1980_CR177","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1111\/os.13136","volume":"13","author":"A Tian","year":"2021","unstructured":"Tian A, Jia H, Zhu S, Lu B, Li Y, Ma J, Ma X (2021) Romosozumab versus teriparatide for the treatment of postmenopausal osteoporosis: a systematic review and meta-analysis through a grade analysis of evidence. Orthop Surg 13(7):1941\u20131950","journal-title":"Orthop Surg"},{"key":"1980_CR178","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00198-020-05639-y","volume":"32","author":"A Tominaga","year":"2021","unstructured":"Tominaga A, Wada K, Kato Y, Nishi H, Terayama Y, Okazaki K (2021a) Early clinical effects, safety, and appropriate selection of bone markers in romosozumab treatment for osteoporosis patients: a 6-month study. Osteoporos Int 32:653\u2013661","journal-title":"Osteoporos Int"},{"key":"1980_CR179","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05925-3","author":"A Tominaga","year":"2021","unstructured":"Tominaga A, Wada K, Okazaki K, Nishi H, Terayama Y, Kato Y (2021b) Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-021-05925-3","journal-title":"Osteoporos Int"},{"issue":"6","key":"1980_CR180","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00198-021-06261-2","volume":"33","author":"A Tominaga","year":"2022","unstructured":"Tominaga A, Wada K, Okazaki K, Nishi H, Terayama Y, Kodama Y, Kato Y (2022) Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment. Osteoporos Int 33(6):1265\u20131273","journal-title":"Osteoporos Int"},{"key":"1980_CR181","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","volume":"39","author":"N Udagawa","year":"2021","unstructured":"Udagawa N, Koide M, Nakamura M, Nakamichi Y, Yamashita T, Uehara S, Kobayashi Y, Furuya Y, Yasuda H, Fukuda C (2021) Osteoclast differentiation by RANKL and OPG signaling pathways. J Bone Miner Metab 39:19\u201326","journal-title":"J Bone Miner Metab"},{"key":"1980_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117921","volume":"256","author":"IA Uehara","year":"2020","unstructured":"Uehara IA, Soldi LR, Silva MJB (2020) Current perspectives of osteoclastogenesis through estrogen modulated immune cell cytokines. Life Sci 256:117921","journal-title":"Life Sci"},{"key":"1980_CR183","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/0378-5122(96)01015-8","volume":"23","author":"HK V\u00e4\u00e4n\u00e4nen","year":"1996","unstructured":"V\u00e4\u00e4n\u00e4nen HK, H\u00e4rk\u00f6nen PL (1996) Estrogen and bone metabolism. Maturitas 23:S65\u2013S69","journal-title":"Maturitas"},{"issue":"3","key":"1980_CR184","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030806","volume":"11","author":"ES Vasiliadis","year":"2022","unstructured":"Vasiliadis ES, Evangelopoulos D-S, Kaspiris A, Benetos IS, Vlachos C, Pneumaticos SG (2022) The role of sclerostin in bone diseases. J Clin Med 11(3):806","journal-title":"J Clin Med"},{"issue":"1","key":"1980_CR185","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11420-015-9469-1","volume":"12","author":"JC Villa","year":"2016","unstructured":"Villa JC, Gianakos A, Lane JM (2016) Bisphosphonate treatment in osteoporosis: optimal duration of therapy and the incorporation of a drug holiday. HSS j\u00ae: Musculoskeletal J Hospital Special Surg 12(1):66\u201373","journal-title":"HSS j\u00ae: Musculoskeletal J Hospital Special Surg"},{"key":"1980_CR186","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pbiomolbio.2022.12.007","volume":"178","author":"J Wang","year":"2023","unstructured":"Wang J, Shang P (2023) Static magnetic field: a potential tool of controlling stem cells fates for stem cell therapy in osteoporosis. Prog Biophys Mol Biol 178:91\u2013102","journal-title":"Prog Biophys Mol Biol"},{"issue":"1","key":"1980_CR187","volume":"2013","author":"M Wang","year":"2013","unstructured":"Wang M, Tian T, Yu S, He N, Ma D (2013) Th17 and Treg cells in bone related diseases. J Immunol Res 2013(1):203705","journal-title":"J Immunol Res"},{"key":"1980_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107370","volume":"94","author":"X Wang","year":"2021","unstructured":"Wang X, Ji Q, Hu W, Zhang Z, Hu F, Cao S, Wang Q, Hao Y, Gao M, Zhang X (2021a) Isobavachalcone prevents osteoporosis by suppressing activation of ERK and NF-\u03baB pathways and M1 polarization of macrophages. Int Immunopharmacol 94:107370","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"1980_CR189","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202007408","volume":"31","author":"Z Wang","year":"2021","unstructured":"Wang Z, Niu Y, Tian X, Yu N, Yin X, Xing Z, Li Y, Dong L, Wang C (2021b) Switching on and off macrophages by a \u201cbridge-burning\u201d coating improves bone-implant integration under osteoporosis. Adv Funct Mater 31(7):2007408","journal-title":"Adv Funct Mater"},{"issue":"1","key":"1980_CR190","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2485959","volume":"2022","author":"W Wang","year":"2022","unstructured":"Wang W, Liu H, Liu T, Yang H, He F (2022) Insights into the role of macrophage polarization in the pathogenesis of osteoporosis. Oxid Med Cell Longev 2022(1):2485959","journal-title":"Oxid Med Cell Longev"},{"key":"1980_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1333993","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Sun B, Wang Y, Gao P, Song J, Chang W, Xiao Z, Xi Y, Li Z, An F (2024) Research progress of targeted therapy regulating Th17\/Treg balance in bone immune diseases. Front Immunol 15:1333993","journal-title":"Front Immunol"},{"key":"1980_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101501","author":"Y Wang","year":"2025","unstructured":"Wang Y, Sun L, Dong Z, Zhang T, Wang L, Cao Y, Xu H, Liu C, Chen B (2025) Targeted inhibition of ferroptosis in bone marrow mesenchymal stem cells by engineered exosomes alleviates bone loss in smoking-related osteoporosis. Mater Today Bio. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101501","journal-title":"Mater Today Bio"},{"issue":"1","key":"1980_CR193","first-page":"43","volume":"30","author":"M W\u0105sowski","year":"2017","unstructured":"W\u0105sowski M, Ta\u0142a\u0142aj M (2017) Osteonecrosis of the jaw and atypical femoral fractures as complications of antiresorptive therapy. Postepy Nauk Med 30(1):43\u201348","journal-title":"Postepy Nauk Med"},{"key":"1980_CR194","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00198-015-3386-5","volume":"27","author":"C Weaver","year":"2016","unstructured":"Weaver C, Alexander D, Boushey C, Dawson-Hughes B, Lappe JM, LeBoff M, Liu S, Looker A, Wallace T, Wang D (2016) Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int 27:367\u2013376","journal-title":"Osteoporos Int"},{"issue":"1","key":"1980_CR195","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.0105-2896.2005.00324.x","volume":"208","author":"MN Weitzmann","year":"2005","unstructured":"Weitzmann MN, Pacifici R (2005) The role of T lymphocytes in bone metabolism. Immunol Rev 208(1):154\u2013168","journal-title":"Immunol Rev"},{"key":"1980_CR196","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1391356","volume":"15","author":"M Wen","year":"2024","unstructured":"Wen M, Li J, Lu B (2024) Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS). Front Pharmacol 15:1391356","journal-title":"Front Pharmacol"},{"key":"1980_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687551","volume":"12","author":"D Wu","year":"2021","unstructured":"Wu D, Cline-Smith A, Shashkova E, Perla A, Katyal A, Aurora R (2021) T-cell mediated inflammation in postmenopausal osteoporosis. Front Immunol 12:687551","journal-title":"Front Immunol"},{"key":"1980_CR198","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jconrel.2024.03.028","volume":"369","author":"T Wu","year":"2024","unstructured":"Wu T, Wang L, Jian C, Gao C, Liu Y, Fu Z, Shi C (2024) Regulatory t cell-derived exosome mediated macrophages polarization for osteogenic differentiation in fracture repair. J Control Release 369:266\u2013282","journal-title":"J Control Release"},{"issue":"1","key":"1980_CR199","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.0105-2896.2005.00336.x","volume":"208","author":"L Xing","year":"2005","unstructured":"Xing L, Schwarz EM, Boyce BF (2005) Osteoclast precursors, RANKL\/RANK, and immunology. Immunol Rev 208(1):19\u201329","journal-title":"Immunol Rev"},{"issue":"9","key":"1980_CR200","volume":"16","author":"PK Yadalam","year":"2024","unstructured":"Yadalam PK, Ramya R, Anegundi RV, Chatterjee S (2024) Graph neural network-based drug gene interactions of wnt\/\u03b2-catenin pathway in bone formation. Cureus 16(9):e68669","journal-title":"Cureus"},{"issue":"5","key":"1980_CR201","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.3390\/ijms25052688","volume":"25","author":"M Yang","year":"2024","unstructured":"Yang M, Zhu L (2024) Osteoimmunology: the crosstalk between T cells, B cells, and osteoclasts in rheumatoid arthritis. Int J Mol Sci 25(5):2688","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1980_CR202","first-page":"3150","volume":"6","author":"X Yang","year":"2021","unstructured":"Yang X, Zhou F, Yuan P, Dou G, Liu X, Liu S, Wang X, Jin R, Dong Y, Zhou J (2021) T cell-depleting nanoparticles ameliorate bone loss by reducing activated T cells and regulating the Treg\/Th17 balance. Bioact Mater 6(10):3150\u20133163","journal-title":"Bioact Mater"},{"key":"1980_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114113","volume":"158","author":"Y Yang","year":"2023","unstructured":"Yang Y, Sheng D, Shi J, Xiao L, Wang Z, Yin Z, Zhuang Q, Chen S, Li Y, Gu Y (2023a) Avicularin alleviates osteoporosis-induced implant loosening by attenuating macrophage M1 polarization via its inhibitory effect on the activation of NF-\u03baB. Biomed Pharmacother 158:114113","journal-title":"Biomed Pharmacother"},{"key":"1980_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.143391","volume":"467","author":"Z Yang","year":"2023","unstructured":"Yang Z, Yang Z, Ding L, Liu C, Zhao F, Chen X, Du C (2023b) Nanoengineering multifunctional extracellular vesicles availably mitigate bone loss in osteoporosis through binding to RANKL and rebalancing the Treg\/Th17 cells. Chem Eng J 467:143391","journal-title":"Chem Eng J"},{"key":"1980_CR205","doi-asserted-by":"publisher","first-page":"1431676","DOI":"10.3389\/fendo.2024.1431676","volume":"15","author":"J Yang","year":"2024","unstructured":"Yang J, Guo X, Cui Z, Guo H, Dong J-N (2024) Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis. Front Endocrinol 15:1431676","journal-title":"Front Endocrinol"},{"issue":"12","key":"1980_CR206","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/cbin.11690","volume":"45","author":"L Yu","year":"2021","unstructured":"Yu L, Hu M, Cui X, Bao D, Luo Z, Li D, Li L, Liu N, Wu Y, Luo X (2021) M1 macrophage-derived exosomes aggravate bone loss in postmenopausal osteoporosis via a microRNA-98\/DUSP1\/JNK axis. Cell Biol Int 45(12):2452\u20132463","journal-title":"Cell Biol Int"},{"issue":"1","key":"1980_CR207","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s13018-023-03920-4","volume":"18","author":"C Yuan","year":"2023","unstructured":"Yuan C, Liang Y, Zhu K, Xie W (2023) Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis. J Orthop Surg Res 18(1):447","journal-title":"J Orthop Surg Res"},{"issue":"5","key":"1980_CR208","first-page":"3505","volume":"19","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang X, Zhao D, Liu B, Wang B, Yu W, Li J, Yu X, Cao F, Zheng G (2019) TGF-\u03b21 promotes the osteoinduction of human osteoblasts via the PI3K\/AKT\/mTOR\/S6K1 signalling pathway. Mol Med Rep 19(5):3505\u20133518","journal-title":"Mol Med Rep"},{"issue":"11","key":"1980_CR209","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1002\/jor.24980","volume":"39","author":"S Zhang","year":"2021","unstructured":"Zhang S, Wang M, Li J, Li Y, Zhou J, Tian Z, Liu C, Yao Q (2021) Vaccine of RANKL mutant conjugated with KLH effectively stabilizing bone metabolism and preventing trabecular microstructural degeneration in osteoporotic rats. J Orthop Res 39(11):2465\u20132473","journal-title":"J Orthop Res"},{"issue":"1","key":"1980_CR210","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12951-021-01231-6","volume":"20","author":"C Zhang","year":"2022","unstructured":"Zhang C, Zhang W, Zhu D, Li Z, Wang Z, Li J, Mei X, Xu W, Cheng K, Zhong B (2022a) Nanoparticles functionalized with stem cell secretome and CXCR4-overexpressing endothelial membrane for targeted osteoporosis therapy. J Nanobiotechnol 20(1):35","journal-title":"J Nanobiotechnol"},{"issue":"22","key":"1980_CR211","doi-asserted-by":"publisher","first-page":"6535","DOI":"10.1039\/D2BM01117D","volume":"10","author":"S Zhang","year":"2022","unstructured":"Zhang S, Zhao L, Chen Z, Zhang L, Li L, Zhao M, Yan L, Liao L, Zhang C, Wu Z (2022b) Macrophage-targeting bioactive glass nanoparticles for the treatment of intracellular infection and subcutaneous abscess. Biomater Sci 10(22):6535\u20136548","journal-title":"Biomater Sci"},{"issue":"6","key":"1980_CR212","first-page":"2417","volume":"15","author":"L Zhang","year":"2023","unstructured":"Zhang L, Guan Q, Wang Z, Feng J, Zou J, Gao B (2023) Consequences of aging on bone. Aging Dis 15(6):2417","journal-title":"Aging Dis"},{"key":"1980_CR214","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11914-017-0358-z","volume":"15","author":"B Zhao","year":"2017","unstructured":"Zhao B (2017) TNF and bone remodeling. Curr Osteoporos Rep 15:126\u2013134","journal-title":"Curr Osteoporos Rep"},{"issue":"6","key":"1980_CR215","first-page":"544","volume":"2","author":"W Zhao","year":"2009","unstructured":"Zhao W, Liu Y, Cahill CM, Yang W, Rogers JT, Huang X (2009) The role of T cells in osteoporosis, an update. Int J Clin Exp Pathol 2(6):544","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"1980_CR216","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12979-020-00202-z","volume":"17","author":"L Zhu","year":"2020","unstructured":"Zhu L, Hua F, Ding W, Ding K, Zhang Y, Xu C (2020) The correlation between the Th17\/Treg cell balance and bone health. Immun Ageing 17(1):30","journal-title":"Immun Ageing"},{"key":"1980_CR217","doi-asserted-by":"crossref","unstructured":"Zhu F., H. Liu Y. Cao B. Dai H. Wu and W. Li (2024) \"The combination of Butyricicoccus pullicaecorum and 3-hydroxyanthranilic acid prevents postmenopausal osteoporosis by modulating gut microbiota and Th17\/Treg.\" European Journal of Nutrition: 1\u201315.","DOI":"10.1007\/s00394-024-03400-3"},{"key":"1980_CR218","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00198-012-1909-x","volume":"23","author":"C Zuo","year":"2012","unstructured":"Zuo C, Huang Y, Bajis R, Sahih M, Li Y-P, Dai K, Zhang X (2012) Osteoblastogenesis regulation signals in bone remodeling. Osteoporos Int 23:1653\u20131663","journal-title":"Osteoporos Int"},{"issue":"1","key":"1980_CR219","doi-asserted-by":"publisher","first-page":"43","DOI":"10.11613\/BM.2013.007","volume":"23","author":"J Zupan","year":"2013","unstructured":"Zupan J, Jeras M, Marc J (2013) Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts. Biochem Med 23(1):43\u201363","journal-title":"Biochem Med"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01980-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01980-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01980-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T11:03:18Z","timestamp":1766055798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01980-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":218,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1980"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01980-y","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ali Afshari, Jafar Karami, and Mitra Abbasifard declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}